Skip Navigation Links
  • What's New?
Invited Speakers
» Nobel Laureates
» List of Speakers
Registration
» Registration Fees
» Registration Form
» Registration Login
BVA.NXT 2012
» What is TWAS/BVA.NXT?
» Program
» BVA.NXT Fellows
» Registration Form
» Registration Login
BioFair
» Exhibitor
» Technical Guidelines
» Floor Plan
» Login
Poster Session
» Invitation
» Guidelines
» Poster Session Form
  • Program
Accommodation & Tours
» Accommodation
» Pre/Post Conference Tours
» Ground Transportation
» Contact Information
Sponsors
» Call for Sponsors
» List of Sponsors
» Registration Form
» Registration Login
BA Resources
» Audio Visual Materials
» Books
» Journals
» Reference Materials
» Subject Guides
  • BVA in the Press
  • Statistical Data
Visitor Information
» Visas
» Airports
» Transportation
» Weather
» Banking and Currency
» Tourist Information
» Arabic Language
» Visiting the Library
» Other Tips
  • FAQ
  • Photo Gallery
  • Newsletter

Speaker Details

 
 

print  
   Biography
 
Dr. Kilama is a Director and Founder of Kilama International Consulting Group, LLC (KICG) and an expert in policy development on healthcare, biotechnology, bioprospecting, and intellectual property. He has experience in pharmaceutical, and agrochemical chemistry. He is a Founder of Global Bioscience Development Institute (GBDI). He developed GBDIs’ Biodiversity, Biotechnology and Law training curricula used in training professionals in Africa and other developing countries. Dr. Kilama is also an expert in evaluation of technical assistance and international trade regulations for their impact on the economic development of developing countries. KICG’s mission is to facilitate good management of IPR at institutional and national levels in emerging markets.

Dr. Kilama facilitated several effective partnerships between multinational corporations and institutions (private and public) in developing nations. Born in Uganda, Dr. Kilama received his PhD in Medicinal Chemistry from the University of Arizona, a Pharmacy degree from the University of Kentucky and Bachelors degree in Chemistry from Berea. Dr. Kilama worked in DuPont as a Senior Medicinal Research Chemist and holds several patents. Dr. Kilama previously served on the Board of Directors of Medicines360, Public Private Partnership for Health (PPPH) Global Forum for Health Research, Geneva, Switzerland and Public Interest Intellectual Property Advisors, Inc., Washington, DC USA. He is currently serving as a Board of Directors of Pytica, Inc. and as an Advisor to Global Health at The Children Hospital of Philadelphia and Scientific Advisor to Institute of One World Health and the International Organization for Chemistry in Development (IOCD), Belgium.
 
 
  Abstract
 
 

Bibliotheca Alexandrina - P.O. Box 138 - Chatby, Alexandria 21526, EGYPT
Phone: +(203) 4839999 General E-mail: biovisionalexandria@bibalex.org